C191202Level 5
Durvalumab/Tremelimumab Regimen
**Semantic type:** Therapeutic or Preventive Procedure
**Definition:** A regimen consisting of durvalumab and tremelimumab that may be used in the treatment of esophageal and esophagogastric junction, hepatocellular, and gastric cancer.
**Synonyms:** - Durvalumab and Tremelimumab - Durvalumab/Tremelimumab - Durvalumab/Tremelimumab-actl Regimen - Imfinzi/Imjudo Regimen - Imjudo/Imfinzi - Tremelimumab/Durvalumab - Tremelimumab/Durvalumab Regimen
GET
/api/v1/systems/nci_thesaurus/nodes/C191202Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.